Inferior Vena Cava Filters (IVCF) Pipeline Analysis with Ongoing Clinical Trials and Recent Developments: 2017 Report


Published on : Apr 18, 2017

Albany, New York, April 18, 2017: The latest pipeline analysis on the rapidly expanding market of inferior vena cava filters, has been recently broadcasted to the broad portfolio of Market Research Hub (MRH). It is titled as “Inferior Vena Cava Filters (IVCF) - Medical Devices Pipeline Assessment, 2017” and offers a precise overview of these filters, which are currently in the pipeline stage. Additionally, It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Inferior Vena Cava Filters (IVCF) pipeline products.

In the first section, the readers will get to know about the market overview of Inferior Vena Cava Filter (IVCF). It is a mechanical device used to prevent blood clots from traveling to lungs. IVC filter traps blood clots before it reaches to the lungs. IVC filters are made of non-ferromagnetic materials [Cobalt Chromium Alloy, Stainless Steel, Titanium, Nickel-Titanium (Nitinol)]. The filter is inserted inside a large vein called the inferior vena cava (which carries blood from lower extremities to the heart). Inferior vena cava filters (IVCF) are used in trauma patients to reduce the incidence of pulmonary embolism (PE). It has been analyzed that, the clinically proven and recognized purpose for this product is to prevent blood clots in deep veins, a condition known as Deep Vein Thrombosis (DVT).

There are two versions of IVC filters are available, which includes retrievable and permanent. The majority of these filters used today are permanent. The FDA recommends that implanting physicians and clinicians responsible for the ongoing care of patients with retrievable IVC filters consider eliminating the filter once protection from pulmonary embolism (PE) is no longer required. At present, the market of inferior vena cava filters is majorly driven by rising incidences of cardiovascular diseases globally. This rise in a number of patients diagnosed with cardiovascular diseases across the world will boost the global inferior vena cava filters market.

Moreover, the report extensively covers the details on IVCF under development based on various stages of development ranging from Early Development to Approved / Issued stage. Also, it identifies and understands important and varied types of Inferior Vena Cava Filters (IVCF) which are under development. For the better understanding of the device, this report is prepared using data sourced from in-house databases, secondary and primary research by the team of industry experts.

In the concluding section, the report reviews the major players involved in the development of Inferior Vena Cava Filters (IVCF) and list all their pipeline projects in detail. Here’s a list of major players outlined in this study:

  • Adient Medical Inc.
  • Contego Medical, LLC
  • Interventional & Surgical Innovations, LLC
  • Veniti Inc
  • Kaleidoscope
  • VueKlar Cardiovascular Ltd
  • Lifetech Scientific (Shenzhen) Co., Ltd.
  • Volcano Corp

Click here to get more info with TOC in a PDF Format: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1054416

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-518-621-2074

+1-866-997-4948US Toll Free

Email : sales@marketresearchhub.com

Back To Top